Single-Cell & Spatial Metabolism: Metabolic Phenotyping of Cells and Tissue (incl. FFPE)
Lab Services
CRO Services (Single-Cell Metabolic Phenotyping)
Data Services
Tri-Omics Data Integration for Actionable Insights
Sample Analysis
Cells, Organoids & Tissues, including FFPE Biopsies
Innovation Alert
Introducing Spatial Metabolic Phenotyping Services
Applications
QSM™ Biomarkers are utilized in pre-clinical, clinical, and translational studies across various disease areas, including drug safety assessments.
Disease Area
​
Oncology
Immuno-Oncology
Immunology
Neurology
Oncology
Gene & Cell Therapy
Study Phase
​
Phase I
Translational
Phase II
Discovery
Pathology
Pre-Clinical
Download Case Study
Applications
About Doppelganger
Bioenergetics underpins all biological processes, with cellular metabolism regulating cellular function, health, and disease. Functional bioenergetic profiling provides powerful biomarkers for drug discovery, enabling earlier and more accurate prediction of therapeutic efficacy, mechanism of action, and safety.
​
The Seahorse XF platform pioneered real-time cellular bioenergetic analysis. Doppelganger Biosystem's proprietary QSM™ platform extends these measurements beyond cultured cells to tissues, quantifying ATP production, oxygen consumption, and the utilization of five key metabolic substrates in fresh, frozen, and FFPE samples, as well as at single-cell and spatial resolution.
​
Doppelganger Biosystem GmbH empowers researchers in drug discovery, preclinical, clinical, and translational research with actionable bioenergetic insights that accelerate biomarker discovery, therapeutic development, and precision medicine.
​
Want to learn more about QSM™?
Contact
Doppelganger Biosystem GmbH
Rebenstrasse 22
26121 Oldenburg, Germany
​
Phone North America:
+1 617 3518 153
Phone Europe:
+49 441 30446185